Subscribe to Newsletter
Subspecialties Business and Innovation

Sitting Down With...

Sitting Down With… Rainer Kirchhübel, CEO, OCULUS Optikgeräte GmbH

Subspecialties Cataract

Yamane: Revisited

| Phoebe Harkin

The pioneer behind double-needle intrascleral IOL fixation, Shin Yamane, introduces the Yamane-Geuder needle guide.

Subspecialties Refractive

Navigating Presbyopia Correction Expectations

Francesco Carones considers the factors influencing patient selection for presbyopia-correcting IOLs.

Subspecialties Basic & Translational Research

Business in Brief

| Phoebe Harkin

Approvals, announcements, acquisitions and an all-new training program for refractive surgeons

Subspecialties Refractive

(Not) Seeing Eye to Eye

| Arthur B. Cummings, Gregory D. Parkhurst, Blake Williamson, Daniel S. Durrie, Guy M. Kezirian, Lance J. Kugler, Jennifer Loh, R. Luke Rebenitsch, Ik Hee Ryu, Evan D. Schoenberg, Jason E. Stahl, Roger Zaldivar

12 surgeons provide a counterpoint to George Beiko’s controversial take on refractive lens exchange.

Subspecialties Basic & Translational Research

From Darkness

| Phoebe Harkin

Introducing a personalized antisense gene therapy for inherited retinal diseases

Subspecialties Basic & Translational Research

Image of the Month

Taken at differing anatomic depths, these monochromatic volume scans offer a detailed visualization of the superior arcade of a non-human primate.

Business & Profession Business and Innovation

The Power To Do Good

| Aleksandra Jones

As you nominate your colleagues for the 2019 Power List, consider the wider impact of your choice.

Subspecialties Business and Innovation

SCHWIND AMARIS product family: High performance eye laser systems from one of the technology leaders

In this exclusive video, Tobias Neuhann, Medical Head at Augenklinik am Marienplatz, explains why Schwind lasers are his first choice.

Subspecialties Basic & Translational Research

Squalamine on Trial

Squalamine may have fascinating origins – originally derived from the livers of the dogfish shark – but as a treatment for wet AMD it has so far failed to have any “bite.”

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: